281 results on '"Tang, W.H. Wilson"'
Search Results
2. Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association
3. Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease From the PVDOMICS Study
4. The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline
5. Obesity and Weight Loss Strategies for Patients With Heart Failure
6. Clinical Outcomes of Metabolic Surgery on Diuretic Use in Patients With Heart Failure
7. Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases
8. Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial
9. Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
10. Race, Genotype, and Prognosis in Black Patients With Transthyretin Cardiac Amyloidosis
11. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
12. Meta-Analysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart Failure
13. Prognostic Value of Hemodynamic Gain Index in Patients With Heart Failure With Reduced Ejection Fraction
14. Cardiac MRI-Enriched Phenomapping Classification and Differential Treatment Outcomes in Patients With Ischemic Cardiomyopathy
15. Hemodynamic Determinants of Cardiac Surgery-Associated Acute Kidney Injury
16. Worsening heart failure: a concept in evolution
17. Rationale and Design of the DECONGEST (Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment) Study
18. 30- and 60-Day Readmission Rates for Children With Heart Failure in the United States
19. Significance of Adipose Tissue Quantity and Distribution on Obesity Paradox in Heart Failure
20. Intra-Aortic Balloon Pump: Uncovering Myths and Misconceptions
21. Emerging Individualized Approaches in the Management of Acute Cardiorenal Syndrome With Renal Assist Devices
22. Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart Failure
23. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure
24. Aortic Valve Disease, Transcatheter Aortic Valve Replacement, and the Heart Failure Patient: A State-of-the-Art Review
25. Ketone ester supplementation suppresses cardiac inflammation and improves cardiac energetics in a swine model of acute myocardial infarction
26. Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study
27. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
28. Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality
29. Negative Predictive Value and Prognostic Associations of Rb-82 PET/CT with Myocardial Blood Flow in CAV
30. Long-term outcomes in nonprogressors to cardiac resynchronization therapy
31. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy
32. Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial
33. Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression
34. Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension
35. Prognostic Power of Quantitative Assessment of Functional Mitral Regurgitation and Myocardial Scar Quantification by Cardiac Magnetic Resonance
36. Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction
37. Pulmonary hypertension across the spectrum of left heart and lung disease
38. Electrical Dyssynchrony in Cardiac Amyloidosis: Prevalence, Predictors, Clinical Correlates, and Outcomes
39. Retinal Microvasculature: A Potential Window Into Heart Failure Prevention
40. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era
41. Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease
42. Burden of Pediatric Heart Failure in the United States
43. Predictive Modeling to Assess Pretest Probability of Transthyretin Gene Variants Based on Demographic Information
44. Contemporary Trends of Clinical Outcomes in Primary Left Ventricular Assist Device Implantation and Postprocedure High-Risk Categories
45. Hemodynamic Response after Intra-aortic Balloon Counter-Pulsation in Cardiac Amyloidosis and Cardiogenic Shock.
46. Comprehensive Clinical and Genetic Analyses of Circulating Bile Acids and Their Associations With Diabetes and Its Indices.
47. Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab
48. Dysregulated amino acid metabolism in heart failure: role of gut microbiome
49. Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis
50. Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.